A092 RMPT in Relapsed/Refractory Multiple Myeloma: Results of a Multicenter Phase II Clinical Trial

Clinical Lymphoma & Myeloma ◽

10.1016/s1557-9190(11)70458-9 ◽

2009 ◽

Vol 9 ◽

pp. S14-S15

Author(s):

A Palumbo ◽

A Larocca ◽

G Sanpaolo ◽

AP Falcone ◽

V Federico ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Refractory Multiple Myeloma ◽

Multicenter Phase

Download Full-text

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial

Leukemia & Lymphoma ◽

10.1080/10428190902912460 ◽

2009 ◽

Vol 50 (7) ◽

pp. 1096-1101 ◽

Author(s):

Asher Chanan-Khan ◽

Kena C. Miller ◽

Laurie Musial ◽

Swaminathan Padmanabhan ◽

Jihnhee Yu ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Phase Ii Clinical Trial ◽

Salvage Regimen ◽

Refractory Multiple Myeloma

Download Full-text

Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Leukemia ◽

10.1038/leu.2017.258 ◽

2017 ◽

Vol 32 (3) ◽

pp. 719-728 ◽

Author(s):

S Ailawadhi ◽

J R Mikhael ◽

B R LaPlant ◽

K M Laumann ◽

S Kumar ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Refractory Multiple Myeloma ◽

Long Term Follow Up

Download Full-text

A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoring

Cancer ◽

10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f ◽

1995 ◽

Vol 75 (4) ◽

pp. 1038-1044 ◽

Author(s):

Reinhard Dummer ◽

Günter Burg ◽

Martin E. Gore ◽

Barry W. Hancock ◽

Pierre J. Guillou ◽

...

Keyword(s):

Clinical Trial ◽

Continuous Infusion ◽

Metastatic Melanoma ◽

Phase Ii ◽

Clinical Data ◽

Phase Ii Clinical Trial ◽

Multicenter Phase

Download Full-text

Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2019.02.071 ◽

2019 ◽

Vol 108 (1) ◽

pp. 167-174 ◽

Author(s):

Paul A.J. Beckers ◽

Michel I.M. Versteegh ◽

Thomas J. Van Brakel ◽

Jerry Braun ◽

Bart Van Putte ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Lung Metastases ◽

Lung Perfusion ◽

Phase Ii Clinical Trial ◽

Multicenter Phase ◽

Isolated Lung Perfusion ◽

Download Full-text

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

10.1158/1538-7445.am2013-4664 ◽

2013 ◽

Author(s):

Edward B. Garon ◽

Jill M. Siegfried ◽

Steven M. Dubinett ◽

Robert M. Elashoff ◽

David J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Multicenter Phase ◽

Previously Treated

Download Full-text

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1013-1013 ◽

Author(s):

F. Dalenc ◽

M. Campone ◽

P. Hupperets ◽

R. O'Regan ◽

C. Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase

Download Full-text

Abstract No LB12: A prospective, multicenter phase II clinical trial using irreversible electroporation for the treatment of early stage HCC

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2012.05.018 ◽

2012 ◽

Vol 23 (8) ◽

pp. 1114 ◽

Author(s):

R. Lencioni ◽

F. Izzo ◽

L. Crocetti ◽

V. Vilgrain ◽

M. Abdel-Rehim ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Early Stage ◽

Irreversible Electroporation ◽

Phase Ii Clinical Trial ◽

Multicenter Phase

Download Full-text

A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma

Nanomedicine Nanotechnology Biology and Medicine ◽

10.1016/j.nano.2009.01.009 ◽

2009 ◽

Vol 5 (4) ◽

pp. 419-423 ◽

Author(s):

Qinghua Zhou ◽

Xun Sun ◽

Lingyuan Zeng ◽

Jie Liu ◽

Zhirong Zhang

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Multicenter Phase

Download Full-text

Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer

Anticancer Research ◽

10.21873/anticanres.11471 ◽

2017 ◽

Vol 37 (3) ◽

pp. 1467-1474 ◽

Keyword(s):

Clinical Trial ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Clinical Trial ◽

Tract Cancer ◽

Multicenter Phase

Download Full-text

Cetuximab Plus Mfolfox-6 As First-Line Therapy for Unresectable Liver Metastasis from Colorectal Cancer: An Open, Non-Randomized, Multicenter Phase II Clinical Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33115-x ◽

2012 ◽

Vol 23 ◽

pp. ix217

Author(s):

S. Cai ◽

W. Zhang ◽

W. Li ◽

Y. Xu ◽

W. Gu ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Liver Metastasis ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Unresectable Liver Metastasis ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text